Table 1.
Variable | All (n = 125) | No history of malignancy (n = 105) | History of malignancy (n = 20) | P |
---|---|---|---|---|
Age at IgG4-RD onset, mean ± SD years | 50.3 ± 14.9 | 48.5 ± 14.3 | 59.8 ± 14.6 | 0.002 |
Male sex | 76 (60.8) | 61 (58.1) | 15 (75) | 0.2 |
White race | 96 (77) | 77 (73) | 19 (95) | 0.04 |
Disease duration prior to evaluation, median (IQR) years | 2 (1–6) | 2.5 (1–6) | 1 (0.5–4.5) | 0.14 |
No. of involved organs, mean ± SD | 2.3 ± 1.3 | 2.3 ± 1.4 | 2.4 ± 1.1 | 0.7 |
Serum IgG4, median (IQR) mg/dl† | 140 (55.1–408) | 121 (49.8–319) | 407.5 (139–655) | 0.03 |
Organ involvement | ||||
Submandibular gland | 35 (28) | 30 (29) | 4 (20) | 0.6 |
Lymph nodes | 34 (27) | 29 (28) | 5 (25) | 1 |
Orbit | 28 (22) | 23 (22) | 4 (20) | 1 |
Pancreas | 24 (19) | 20 (19) | 4 (20) | 1 |
Retroperitoneum | 25 (20) | 21 (20) | 4 (20) | 1 |
Except where indicated otherwise, values are the number (%). IgG4-RD = IgG4-related disease; IQR = interquartile range.
Among patients with active disease at the initial visit.